Please login to the form below

medicines access

This page shows the latest medicines access news and features for those working in and with pharma, biotech and healthcare.

Takeda offloads select portfolio to Acino ahead of Shire takeover

We will do this via our commercial activities and Takeda’s Access to Medicines programme,” said Ricardo Marek, President, Growth and Emerging Markets Business Unit, Takeda. ... We are confident that Acino is best positioned to provide uninterrupted

Latest news

NICE turns down Roche’s Tecentriq for triple-negative breast cancer

diagnosed with TNBC in England would be eligible for treatment with the regimen if an access deal can be agreed. ... Early Access to Medicines Scheme which had made it temporarily available is no longer an option for new patients.”.
Significant gaps remain in UK’s no-deal Brexit prep, says NAO report

Medicine supply still under threat despite preparedness programme. A no-deal Brexit could still threaten supplies of medicines to the NHS and care homes, despite the UK government’s preparedness programme, ... shortages of vital medicines, despite the
Vertex scores CF deal with Scotland, but access debate continues

This is the first agreement within the UK for access to Vertex's CF medicines, and comes following a long history of pricing disagreements, most notably between the pharma company, NHS ... Campaigners and patient groups have continually called for access,
Novartis expands its generics franchise with natalizumab biosimilar

According to Novartis, affordability is a significant challenge for MS medicines, with a recent report highlighting that it is the most common challenge affecting access to MS therapy in 46% of ... Patient access to advanced medicines is important for
Who's calling the shots in European healthcare?

Natsis is policy manager for Universal Access and Affordable Medicines at the European Public Health Alliance (EPHA), a Brussels-based organisation made up of public health NGOs, patient groups, health professionals ... What I care about is how people

More from news
Approximately 4 fully matching, plus 427 partially matching documents found.

Latest Intelligence

Evolution or revolution: the latest review of NICE methods

on Access to Medicines and Medical Devices evidence sessions on the NICE methods review inquiry. ... Leela worked as an advisor to the Department of Health and Social Care on the 2019 Voluntary Scheme for Branded Medicines Pricing and Access (VPAS).
Leading AstraZeneca’s return to growth in Europe

Europe’s market access and competitiveness. Of course, that highly developed payer environment also helps to put the brakes on uptake of new medicines in Europe. ... Europe is complex when it comes to access and reimbursement. How we work with payers
The Cystic Fibrosis Buyers’ Club

Diarmaid McDonald is lead organiser of Just Treatment, a UK-based patient activist group which is challenging the government to take whatever steps necessary to ensure access to new medicines at ... Instead, they identified a legal loophole which allows
The UK’s new medicines pricing deal – opportunities and risks for pharma

NHSE has sought a far stronger role when it comes to medicines pricing and access since it formally began its work in 2013. ... Getting medicines to patients. Like its predecessor, the 2019 VPAS directly addresses medicines access to patients, with the
The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt

The deal is done. After undoubtedly tense negotiations, the heads of terms for the new Voluntary Scheme for Branded Medicines Pricing and Access have just been published, and although some among ... By Leslie Galloway, chairman, Ethical Medicines

More from intelligence
Approximately 0 fully matching, plus 87 partially matching documents found.

Latest appointments

Pfizer’s Alan Maine moves to Edelman

Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area ... During his time at Pfizer, Maine also
Sobi names Holly May VP of sales and marketing, US

May’s new role will see her lead the biopharma’s commercial team in bringing Sobi’s medicines to the country. ... She will also collaborate with the operations and patient access team to ensure the medicines are accessible to as many appropriate
Inceptua Medicines Access appoints senior new-hires

Multipharma’s new speciality business unit, Inceptua has appointed Ruth Rostron as its new senior project manager, a role that will see her focus on design and implementation of medicines access
Sandoz UK promotes Tim de Gavre to country head

As a company, Sandoz has an exciting portfolio of medicines and future product pipeline. ... I look forward to working with the Sandoz team, and in partnership with the NHS to help patients access these important medicines.”.
Takeda UK & Ireland appoints market access director

Takeda UK &Ireland has appointed Peter Wheatley Price as market access director, succeeding Ross Selby who moves to head the firm's new US-based global pricing, market access and health ... He also brings experience form Boehringer Ingelheim, where he

More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest from PMHub

New opportunities in emerging markets

This growth is set to continue. In parallel, we are seeing an increased focus among emerging market governments on public healthcare reform: expanding their populations’ access to medicines by establishing universal ... Greater purchasing power and
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices.
The Valid Insight visit to Buckingham Palace

help them to keep advancing patient access to medicines. ... our clients’ products’ success, but accelerates and improves patient access to new and innovative medicines.
Uniphar Group plc appoints Graham McIntosh as Managing Director Commercial & Clinical (Pharma)

McIntosh believes this to be an exciting time for the industry, embracing the vision to improve patient access to pharmaceutical medicines and treatments by developing connectivity between manufacturers and healthcare stakeholders. ... service which adds
Precision medicine from concept to clinic

We have spoken to these stakeholders to chart their journeys and the role they play in ensuring patients can access precision medicines. ... Here, we reveal key insights to help you meet the needs of seven core stakeholders involved in launching and